Cargando…
Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer
Ovarian cancer is the second most fatal gynecological cancer. For the last decade or so significant use of non-circulating and circulating biomarkers has been highlighted. However, the study of such biomarkers at nanovesicle technology such as exosomes, proteomic and genomics studies could further c...
Autores principales: | Utkarsh, Kumar, Kumar, Abhishek, Aditi, Khan, Azhar, Nayyar, Ashima, Haque, Shabirul, Iqbal, Shams |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308119/ https://www.ncbi.nlm.nih.gov/pubmed/37396515 http://dx.doi.org/10.1016/j.gendis.2022.07.004 |
Ejemplares similares
-
Circulating nucleic acids as biomarkers in breast cancer
por: Schwarzenbach, Heidi
Publicado: (2013) -
Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes
por: Padilla-Martinez, Felipe, et al.
Publicado: (2021) -
Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
por: McGowan, Ryan, et al.
Publicado: (2022) -
Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules
por: Ajit, Seena K.
Publicado: (2012) -
Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
por: Rahat, Beenish, et al.
Publicado: (2020)